These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31496905)

  • 21. Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease.
    Manghat P; Fraser WD; Wierzbicki AS; Fogelman I; Goldsmith DJ; Hampson G
    Osteoporos Int; 2010 Nov; 21(11):1853-61. PubMed ID: 20012018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influences of nutrition and adiposity on bone mineral density in individuals with chronic spinal cord injury: A cross-sectional, observational study.
    Doubelt I; Totosy de Zepetnek J; MacDonald MJ; Atkinson SA
    Bone Rep; 2015 Jun; 2():26-31. PubMed ID: 28377950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients.
    Zheng S; Chen Y; Zheng Y; Zhou Z; Li Z
    Eur J Med Res; 2018 Apr; 23(1):18. PubMed ID: 29665846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients.
    Lee WT; Fang YW; Chen M; Liou HH; Lee CJ; Tsai MH
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men.
    Marsell R; Mirza MA; Mallmin H; Karlsson M; Mellström D; Orwoll E; Ohlsson C; Jonsson KB; Ljunggren O; Larsson TE
    Osteoporos Int; 2009 Jul; 20(7):1167-73. PubMed ID: 18974917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble receptor activator of NFkappa B-ligand and osteoprotegerin in rheumatoid arthritis - relationship with bone mineral density, disease activity and bone turnover.
    Oelzner P; Franke S; Lehmann G; Eidner T; Müller A; Wolf G; Hein G
    Clin Rheumatol; 2007 Dec; 26(12):2127-2135. PubMed ID: 17541498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum adiponectin and bone mineral density in male hemodialysis patients.
    Okuno S; Ishimura E; Norimine K; Tsuboniwa N; Kagitani S; Yamakawa K; Yamakawa T; Sato KK; Hayashi T; Shoji S; Nishizawa Y; Inaba M
    Osteoporos Int; 2012 Jul; 23(7):2027-35. PubMed ID: 21927917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.
    Bai XL; Liang TB; Wu LH; Li DL; Geng L; Wang WL; Shen Y; Zhang M; Zheng SS
    Transplant Proc; 2007 Dec; 39(10):3182-5. PubMed ID: 18089348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 25-Hydroxyvitamin D deficiency and diabetes predict reduced BMD in patients with chronic kidney disease.
    Elder GJ; Mackun K
    J Bone Miner Res; 2006 Nov; 21(11):1778-84. PubMed ID: 17002574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients.
    Ersoy FF; Passadakis SP; Tam P; Memmos ED; Katopodis PK; Ozener C; Akçiçek F; Camsari T; Ateş K; Ataman R; Vlachojannis JG; Dombros AN; Utaş C; Akpolat T; Bozfakioğlu S; Wu G; Karayaylali I; Arinsoy T; Stathakis PC; Yavuz M; Tsakiris JD; Dimitriades CA; Yilmaz ME; Gültekin M; Karayalçin B; Yardimsever M; Oreopoulos DG
    J Bone Miner Metab; 2006; 24(1):79-86. PubMed ID: 16369903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlations of new markers of bone formation and resorption in kidney transplant recipients.
    Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M
    Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D status and its relationship with bone mineral density and parathyroid hormone in Southeast Asian adults with low bone density.
    Chandran M; Hoeck HC; Wong HC; Zhang RF; Dimai HP
    Endocr Pract; 2011; 17(2):226-34. PubMed ID: 21041169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients.
    Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Tziamalis MP; Stathakis CP; Diamanti-Kandarakis E; Dimitroulis D; Perrea DN
    J Bone Miner Metab; 2008; 26(1):66-72. PubMed ID: 18095066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of bone mineral density in CAPD patients with dual energy X-ray absorptiometry.
    Pasadakis P; Thodis E; Mourvati E; Euthimiadou A; Margaritis D; Manavis J; Vargemezis V
    Adv Perit Dial; 1996; 12():245-9. PubMed ID: 8865913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone mineral density and bone turnover markers in children with chronic renal failure.
    Bakr AM
    Pediatr Nephrol; 2004 Dec; 19(12):1390-3. PubMed ID: 15517415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C; Ljunggren Ö; Nilsson-Ehle H; Karlsson MK; Herlitz H; Lorentzon M; Ohlsson C; Mellström D
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.
    Haarhaus M; Fernström A; Magnusson M; Magnusson P
    Nephrol Dial Transplant; 2009 Nov; 24(11):3382-9. PubMed ID: 19542194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.